Landmark Bancorp (NASDAQ:LARK) reported quarterly earnings of $0.61 per share. This is a 38.38 percent decrease over earnings of $0.99 per share from the same period last year.
SpringWorks Therapeutics To Present At ASCO Jun. 5
- Initial Data to be Presented from GSK-Sponsored Phase 1/2 Study Evaluating Nirogacestat in Combination with Low-Dose BLENREP in Patients with Relapsed or Refractory Multiple Myeloma -
- Long-Term Follow-up Data from